These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8393159)

  • 1. Identification of a DNA element that can enhance p53-mediated transactivation.
    Shiio Y; Yamamoto T; Yamaguchi N
    Oncogene; 1993 Aug; 8(8):2059-65. PubMed ID: 8393159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
    Inga A; Resnick MA
    Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of p53 transactivation through high-affinity binding sites.
    Chumakov AM; Miller CW; Chen DL; Koeffler HP
    Oncogene; 1993 Nov; 8(11):3005-11. PubMed ID: 8414502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 binds to a novel recognition sequence in the proximal promoter of the rat muscle creatine kinase gene and activates its transcription.
    Zhao J; Schmieg FI; Logsdon N; Freedman D; Simmons DT; Molloy GR
    Oncogene; 1996 Jul; 13(2):293-302. PubMed ID: 8710368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A conserved intronic response element mediates direct p53-dependent transcriptional activation of both the human and murine bax genes.
    Thornborrow EC; Patel S; Mastropietro AE; Schwartzfarb EM; Manfredi JJ
    Oncogene; 2002 Feb; 21(7):990-9. PubMed ID: 11850816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of human polyomavirus BK with the tumor-suppressor protein p53.
    Shivakumar CV; Das GC
    Oncogene; 1996 Jul; 13(2):323-32. PubMed ID: 8710371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 transactivation through various p53-responsive elements.
    Park DJ; Chumakov AM; Miller CW; Pham EY; Koeffler HP
    Mol Carcinog; 1996 Jun; 16(2):101-8. PubMed ID: 8645424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive effect between NF-kappaB subunits and p53 protein for transcriptional activation of human p53 promoter.
    Benoit V; Hellin AC; Huygen S; Gielen J; Bours V; Merville MP
    Oncogene; 2000 Sep; 19(41):4787-94. PubMed ID: 11032029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the Oct-1 regulatory element of the gadd45 promoter in the p53-independent response to ultraviolet irradiation.
    Takahashi S; Saito S; Ohtani N; Sakai T
    Cancer Res; 2001 Feb; 61(3):1187-95. PubMed ID: 11221850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The requirement of the carboxyl terminus of p53 for DNA binding and transcriptional activation depends on the specific p53 binding DNA element.
    Zhang W; Guo XY; Deisseroth AB
    Oncogene; 1994 Sep; 9(9):2513-21. PubMed ID: 8058314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ets-1 binds cooperatively to the palindromic Ets-binding sites in the p53 promoter.
    Baillat D; Laitem C; Leprivier G; Margerin C; Aumercier M
    Biochem Biophys Res Commun; 2009 Jan; 378(2):213-7. PubMed ID: 19022222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage.
    Jin S; Fan F; Fan W; Zhao H; Tong T; Blanck P; Alomo I; Rajasekaran B; Zhan Q
    Oncogene; 2001 May; 20(21):2683-90. PubMed ID: 11420680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53.
    Kim E; Rohaly G; Heinrichs S; Gimnopoulos D; Meissner H; Deppert W
    Oncogene; 1999 Dec; 18(51):7310-8. PubMed ID: 10602486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further characterisation of the p53 responsive element--identification of new candidate genes for trans-activation by p53.
    Bourdon JC; Deguin-Chambon V; Lelong JC; Dessen P; May P; Debuire B; May E
    Oncogene; 1997 Jan; 14(1):85-94. PubMed ID: 9010235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation-specific transcriptional regulation of the ESE-2 gene by a novel keratinocyte-restricted factor.
    Tummala R; Sinha S
    J Cell Biochem; 2006 Mar; 97(4):766-81. PubMed ID: 16229011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A polymorphic microsatellite that mediates induction of PIG3 by p53.
    Contente A; Dittmer A; Koch MC; Roth J; Dobbelstein M
    Nat Genet; 2002 Mar; 30(3):315-20. PubMed ID: 11919562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tax protein of HTLV-1 inhibits CBP/p300-mediated transcription by interfering with recruitment of CBP/p300 onto DNA element of E-box or p53 binding site.
    Suzuki T; Uchida-Toita M; Yoshida M
    Oncogene; 1999 Jul; 18(28):4137-43. PubMed ID: 10435595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic transcriptional activation of the MCK promoter by p53: tetramers link separated DNA response elements by DNA looping.
    Jackson P; Mastrangelo I; Reed M; Tegtmeyer P; Yardley G; Barrett J
    Oncogene; 1998 Jan; 16(2):283-92. PubMed ID: 9464547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mechanism for p53 to regulate its target gene ECK in signaling apoptosis.
    Jin YJ; Wang J; Qiao C; Hei TK; Brandt-Rauf PW; Yin Y
    Mol Cancer Res; 2006 Oct; 4(10):769-78. PubMed ID: 17050670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased p53 transcription prior to DNA synthesis is regulated through a novel regulatory element within the p53 promoter.
    Boggs K; Reisman D
    Oncogene; 2006 Jan; 25(4):555-65. PubMed ID: 16158047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.